Fosaprepitant Injection, Powder, Lyophilized, For Solution
Product Images NDC 83634-776

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fosaprepitant (NDC 83634-776). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avenacy, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Fos0f 0000 01)

Chemical structure diagram of fosaprepitant dimeglumine, showing the detailed molecular arrangement of the active ingredient in the product Fosaprepitant injection, powder, lyophilized, for solution, 150 mg/5 mL by Avenacy, LLC.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Fos0f 0000 02)

Label for Fosaprepitant 150 mg per vial injection, powder lyophilized for solution for intravenous use. The label states single-dose vial with storage instructions refrigerated at 2°C to 8°C (36°F to 46°F). Manufactured for Avenacy, LLC, Schaumburg, IL, made in China. NDC 83634-776 is shown along with a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.